Nicotex Tablet was developed for people who have a strong tendency or addiction to smoking cigarettes and are trying to quit, as well as tobacco chewers. It performs the dual work of helping to quit smoking and supporting the patient while they withdraw from nicotine.
It may also be used to help in treatment of disorders like depression. Nicotex uses Bupropion as the active ingredient and is manufactured by Cipla.
The active ingredient of Nicotex is Bupropion - 150 MG.
It is available as a tablet, and also as flavoured chewing gum, available in the flavours paan, cinnamon, and mint.
Nicotex tablet and Nicotex chewing gum are used to support smokers as they quit smoking. Smoking can be very addictive; many smokers need help with managing their withdrawal symptoms from nicotine and smoking.
Nicotex tablet and gum is also intended to help those who consume other forms of tobacco, such as chewing tobacco.
Nicotex has been developed by well-known pharma company, Cipla for the precise purpose of helping in quitting smoking, and is commonly used during the withdrawal period to transition to non-smoking, and cessation of tobacco.
Even with Nicotex, it can be expected that some of the side-effects of withdrawal from nicotine will be felt by the patient, including mood swings. However, Nicotex itself may cause certain side-effects. Typically, these are mild and do not continue beyond a period of time. If symptoms become moderate or major, and are persistent, then the patient should consult their physician.
A common dose for tobacco chewers is:
For smokers, Cipla recommends that
Cipla warns that the maximum use of Nicotex is 24 pieces in a 24 hour period. They also provide a 12 week recommendation for usage of Nicotex on their website.
Physicians will always recommend dosage only after consulting their patient’s medical history, their health status, and any other conditions that they may have, as all of these can affect the working of the medicine.
Nicotex works on the principle of nicotine replacement therapy, allowing patients to quit smoking by providing nicotine from the tablet or gum which is non-carcinogenic. It also helps to improve the patient's condition by inhibiting the reuptake of norepinephrine and dopamine.
Patients with certain pre-existing conditions may face problems or increased risk of side-effects from this medication.
There are a few substitutes working on nicotine replacement therapy, and using the same active ingredient, but Nicotex is by far the most common of that which is available on the market.
Frenquit 4mg Pastilles manufactured by Alkem Laboratories Ltd
2Baconil 4mg Nicotine Gums manufactured by Rusan Pharma Ltd is another substitute that can be used for nicotine replacement therapy.
Patients should inform their doctor of any medication that they are taking or may be taking at the same time as Nicotex, including herbal or Ayurveda supplements.
There are number of medicines which may interact with Nicotex. While side-effects and risks are rarely very dangerous, only a physician can make the right choice of dosage to work correctly with your combination of medicines. There is a chance that other medicine would render Nicotex moot.
Ans: Nicotex of any sort, including the 2mg gum, is probably unsafe to use for pregnant and breastfeeding women. There is evidence of higher risk of birth defects for the foetus if the pregnant woman is using Nicotex.
While there is less evidence of danger from breastfeeding, it is possible that there will be risks to the child.
Do not use without consulting your physician if you are pregnant or breastfeeding.
Ans: Nicotex is intended to work as a transitional help for smokers and tobacco chewers who are otherwise finding it difficult to quit. Nicotex makes it easier to quit smoking, and the treatment is intended to slowly reduce use of Nicotex as well.
Nicotex is not harmful in the way cigarettes or tobacco chew are, because it is non-carcinogenic. It does not contain any cancer-causing elements.
Disclaimer : Docprime doesn’t endorse or take any guarantee of the accuracy or completeness of information provided under this article and these are the views strictly of the writer. Docprime shall not be held responsible for any aspect of healthcare services administered with the information provided on this article.